EconPapers    
Economics at your fingertips  
 

Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?

Roland Linder (), J. Zeidler, Florian Verheyen, J.-M. Graf Schulenburg, A. Haverich and T. Schilling
Additional contact information
Roland Linder: Wissenschaftliches Institut der Techniker Krankenkasse (WINEG)
J. Zeidler: Leibniz University Hannover
J.-M. Graf Schulenburg: Leibniz University Hannover
A. Haverich: Hannover Medical School
T. Schilling: Hannover Medical School

The European Journal of Health Economics, 2018, vol. 19, issue 6, No 6, 830 pages

Abstract: Abstract The national guidelines for treatment of chronic coronary heart disease (CHD) recommend surgical coronary aortic bypass grafting (CABG) rather than percutaneous coronary intervention (PCI) for patients with a coronary three-vessel disease. The epidemiology of three-vessel CHD and data about the application of different revascularisation strategies raise suspicion of deviation from the guidelines in the treatment of those patients. Claims data containing records of almost 10 million patients of the largest German statutory health insurance fund (Techniker Krankenkasse) were utilised to measure adherence to the guidelines for treatment of groups of patients with one-, two-, and three-vessel CHD, respectively. The impact of age, sex, and comorbidity on each patient’s revascularisation procedure was investigated as well. There was no significant difference in the rate of PCI between the groups. In conclusion, the hypothesis that patients with a coronary three-vessel disease are not always treated according to the recommendations of the national guidelines could not be disproved by this study. Finally, the results of this study suggest that the best revascularisation strategy for each patient with two- and three-vessel disease should be decided upon by an interdisciplinary discussion between both cardiologists and cardiac surgeons.

Keywords: Chronic coronary heart disease; Coronary aortic bypass grafting; Percutaneous coronary intervention; Claims data; Health services research (search for similar items in EconPapers)
JEL-codes: I10 I19 (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10198-017-0924-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:19:y:2018:i:6:d:10.1007_s10198-017-0924-4

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-017-0924-4

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-04-06
Handle: RePEc:spr:eujhec:v:19:y:2018:i:6:d:10.1007_s10198-017-0924-4